Agenda Topics- Academic Technology Transfer: Due Diligence, Development and Commercialisation
- Building and Financing Drug Discovery Efforts in Academia
- Functional Genomics Technologies in 2014
- Identifying and Working with CRO's
- Novel and Enabling Screening Technologies in 2014
- Public - Private Partnerships
- RNAi and Genome Editing Technologies
- Target versus Phenotypic Based Discovery
- Vendor/User Perspectives on HCA in 2014
Sponsorship and Exhibition OpportunitiesExhibition Team, exhibitors@selectbio.com +44 (0) 1206 501654
|
Confirmed Participants to dateGeoffrey Bartholomeusz, Assistant Professor, MD Anderson Cancer Center Bhavneet Bhinder, Bioinformatics Engineer, Memorial Sloan Kettering Cancer Center Christine Brideau, Vice President of In Vitro Biology, WuXi Rick Cope, Regional Sales Manager, SensíQ Technologies Inc. Susan Dilorio, Director, Qiagen Yuhong Du, Assistant Professor and Associate Director, Emory University Anka Ehrhardt, Director Clinical Flow Cytometry, Bristol-Myers Squibb Jeanne Farrell, Business Development Director, Ichan School of Medicine Iain Fraser, Head Laboratory of Systems Biology, National Institutes of Health Haian Fu, Professor and Director, Emory University Kamyar Hadian, Group Leader, Helmholtz Zentrum München Tim Hammonds, Deputy Director Drug Discovery, Cancer Research Technology Ann Hoffman, Investigator, GSK Thierry Langer, CEO, Prestwick Chemical Scott Martin, Group Leader, RNAi Screening, NCATS, NIH Viviane Martin, Associate Director, Penn State Hershey Medical Center Madhu-Lal Nag, Research Scientist, NCATS, NIH Richard Neubig, Professor and Chair, Michigan State University Chris Porter, Assistant Professor / Pediatrics, University of Colorado School of Medicine Nitin Puri, Associate Director, Product Management, Life Technologies Arumugham Raghunathan, Sr. Director, Business Development, North America , Horizon Discovery Ltd Terry Riss, Senior Product Manager, Cell Health, Promega Corporation Charles Sacco, Entrepreneur in Residence and Director of External Relations, Drexel University David Shum, Assay Development Specialist, Memorial Sloan-Kettering Cancer Center Jean-Philippe Stephan, Senior Scientist, Genentech Steve Titus, Field Application Scientist, GE Healthcare Chris Willis, Solution Scientist, Thomson Reuters Roland Wolkowicz, Associate Professor, San Diego State University Chi Yun, Director, NYU School Of Medicine Litao Zhang, Vice President/Leads Discovery & Optimization, Bristol-Myers Squibb
|